Aging and Heart Failure

Changing demographics of the aging population with heart failure and implications for therapy.- Biology of aging and implications for heart failure therapy and prevention.- Hypertension and prevention of diastolic heart failure in the aging population.- Aging and optimal therapy of systolic heart failure in the elderly.- Atrial fibrillation and heart failure in the aging population.- Optimizing therapy of heart failure in the aging population with monitoring in clinics.- Cardiac alterations in aging, hypertension and diastolic heart failure.- Polypharmacy and adverse drug reactions in the aging population with heart failure.- Aging-related changes in vascular biology and implications for heart failure therapy in the aging population.- Biomarkers and optimal management of heart failure in the aging population.- Benefits of Exercise in the elderly.- The RAAS in heart failure: an update on clinical trials and opportunities for therapy.- Aging and diastolic dysfunction – the interplay of inflammation and extracellular matrix regulation.- Reperfusion and vasodilator therapy in elderly patients with STEMI and heart failure. Improving outcomes.- Erythropoietin therapy for heart failure.- Role of resistin in heart failure in the elderly.- Role of coronary artery calcium in cardiovascular risk stratification and management in the aging population.- Aging-and remodeling of the RAS and RAAS and related pathways. Implications for heart failure therapy.- Aging and right ventricular failure from pulmonary hypertension: Effect of right ventricular and pulmonary artery remodeling.- Biomarkers of cardiovascular aging.- Changes in the heart that accompany advancing age: Humans to molecules.- Aging-related changes in cell death and cell survival pathways and implications for heart failure therapy.- Aging-related changes in telomeres and telomerases and implications for heart failure therapy.- Aging associated alterations in myocardial inflammation and fibrosis: pathophysiological perspectives and clinical implications.- Aging-related changes in extracellular matrix: implications for ventricular remodeling following myocardial infarction.- Calcium handling defects and changes in cardiac function in the aging heart.- Integrins: Implications for aging in heart failure therapy.- Adipokines as novel biomarkers in aging and heart failure.- Aging-related changes in cellular and molecular mechanisms of post-infarction remodeling. Implications for heart failure therapy.- Aging-related changes in mitochondrial function and implication for heart failure therapy.- Regulation of SERCA via oxidative modifications: Implications for the pathophysiology of diastolic dysfunction in the aging heart.- SMP-30 and aging-related cardiac remodeling and heart failure.